NT PHARMA (01011) issues 847.6 million subscription shares.
TaiLing Pharmaceuticals (01011) announced that, based on the specific authorization approved at the special shareholders' meeting held on August 28, 2026, it will allocate and issue 847.6 million subscription shares.
NT PHARMA (01011) announced that, based on the specific authorization approved at the special shareholders' meeting held on August 28, 2026, it will allocate and issue 847.6 million subscription shares.
Related Articles
WUXI BIO (02269) issued 3.2 million shares as a result of option exercises.
YIXIN (02858) canceled 9.1935 million repurchased shares on September 4.
STAR CM (06698) repurchased 11,700 shares at a cost of HKD 9,722.21 on September 4.
WUXI BIO (02269) issued 3.2 million shares as a result of option exercises.
YIXIN (02858) canceled 9.1935 million repurchased shares on September 4.
STAR CM (06698) repurchased 11,700 shares at a cost of HKD 9,722.21 on September 4.
RECOMMEND
